Summary Interleukin 1a (IL-ia), Interleukin 6 (IL-6) and epidermal growth factor (EGF) were tested for their ability to regulate epithelial cervical cell cytokine production and secretion and to induce proliferation of human normal and neoplastic epithelial cervical cells. IL-1 a, and IL-6 enhanced tumour and normal cell growth by 20-120%. The interleukins efficacy was similar to that of EGF for some cell lines but not for normal esocervical cells. The stimulatory effects of the interleukins were observed in both human papilloma virus (HPV)-infected and HPVnon-infected cervical cells. Normal cells constitutively expressed IL-i a, IL-6 and EGF mRNA. All cell lines except C33A expressed IL-i a mRNA. CaSki, C-411 and HT-3 expressed mRNA for IL-6. IL-1 a induced or increased IL-6 mRNA levels in the Me-180 and HT-3 lines and in normal cervical cells. IL-6 induced: (1) the expression of its own mRNA only in Me-180 cells that constitutively lacked IL-6 mRNA; (2) the expression of IL-1 a mRNA in C-33A and increased IL-1 a mRNA level in the case of Mei 80 cells. Increased amounts of IL-6 mRNA were found in normal cells when treated with IL-1 a. In spite of the pattern of mRNA expression, only HT-3 and normal cervical cells constitutively secreted IL-6, and only normal cells were able to produce IL-1 a protein. A significant IL-1 a-dependent increase of IL-6 secretion was found in Me-180, HT-3 and normal cells. IL-ia-and IL-6-driven cell proliferations were almost completely inhibited by the addition of neutralizing anti-IL-6 antibodies. Taken together, these data suggest that interleukins play a role in cervical carcinogenesis as autocrine and/or paracrine stimuli.
and extend them to normal cervical cells, and we also compare the extent of the IL-la and IL-6 stimulatory effect with that produced by epidermal growth factor (EGF). Our findings suggest that IL-1 a and IL-6 can play a role in cervical tumour progression.
MATERIALS AND METHODS

Cervical cell cultures
Normal epithelial cervical cells were isolated using a two-step enzymatic digestion with dispase and trypsin, as described by Pirisi et al (1988) . Briefly, tissues from hysterectomies for endometriosis or fibroids were incubated overnight at 4°C in phosphate-buffered saline (PBS) containing 25 U ml-l of dispase (Gibco-Life Technologies, Grand Island, NY, USA). On the following day, the ectocervical epithelium was lifted from the submucosa, recovered as an intact sheet, and further incubated at 37°C for 30 min in the presence of 0.13% trypsin (Gibco Life Technologies) with frequent agitation. Single-cell preparations were seeded and cultured in collagen IV-coated plates (Becton Dickinson, Bedford, MA, USA) in complete MCDB 153 medium, i.e. in MCDB 153 base medium (Sigma, Milan, Italy) supplemented with 25 gg ml-of bovine pituitary extract (BPE, Becton Dickinson), 0.2 ng ml-1 human recombinant EGF (Becton Dickinson), 5 ,ug ml insulin, 5 ,ug ml' transferrin, 2 mm glutamine, 0.1 mm phosphoethanolamine and 0.1 mm ethanolamine (Sigma) . The purity of these preparations was checked by immunostaining with anti-cytokeratin 14 and anti-cytokeratin 18 antibodies (Woodworth et al, 1993) . Cervical carcinoma cell lines (ME-180, C-411, CaSki, HT-3 and C-33A) were obtained from ATCC (Rockville, MD, USA) and maintained in culture as 
Cell growth assay
Normal and neoplastic cells (1-3x 104 cells ml-') in complete MCDB153 medium were plated into 24-well plates. Collagen IVcoated plates were used for normal cell cultures. After 18 h, the cells were rinsed once with PBS and then maintained in complete MCDB153 medium without EGF and BPE in the presence or absence of cytokines. Optimal cytokine concentrations, as assessed by preliminary experiments, were 100 U ml, 50 U ml-' and 2.5 U ml-for ILl-a, IL-6 and EGF (PeproTech, London, UK) respectively. Specific activities were 10 000 U ig-' for IL-la, 5000 U ig-' for IL-6 and 500 U jg-' for EGF. Quadruplicate haemocytometer counts of triplicate cultures were performed after 7-11 days.
Neutralization
To test the ability of specific monoclonal anti-IL-6 neutralizing antibodies (anti-IL-6, Genzyme, Cambridge, MA, USA) to block the growth-enhancing effect displayed by exogenous IL-la, IL-6 and EGF on cervical cells, cells were plated as above and then incubated in the presence or in the absence of these cytokines with (10 jg ml-') or without anti-IL-6 antibodies.
Elisa
The amounts of IL-la, and Message amplification by reverse transcription-PCR Normal and neoplastic cells were seeded in 60-mm Petri dishes, cultured and treated with cytokines (for 24 h), as reported for ELISA assay. Total RNA was isolated from cells grown in culture by a guanidinium thiocyanate-phenol-chloroform extraction and alcohol precipitation procedure using the Ultraspec RNA isolation system (Biotecx, Houston, TX, USA). Extracted RNA was analysed for integrity using electrophoresis through a 2% formaldehyde-agarose gel. The amount of total RNA was quantified by reading its absorption at 260 nm.
Total RNA (1 jg) was reverse transcribed in a final volume of a 20 gl reaction mixture containing: 10 mM Tris-HCl (pH 8.3), 50 mm potassium chloride, 5 mm magnesium chloride, 400 jM of dATP, dCTP, dGTP and dTTP (Pharmacia, Piscataway, NJ, USA), 2.5 jiM oligo dT primers, 20 units RNAase inhibitor, and 50 units murine leukaemia virus reverse transcriptase (Perkin-Elmer Cetus, Norwalk, CT, USA). The mixture was incubated at room temperature for 30 min, at 42°C for 30 min, heated to 95°C for 5 min and stored at -20°C. cDNA was denatured by heating to 95°C for PCR analysis performed as reported above is not really quantitative. However, a strong increase in the intensity of a band after a given treatment strongly suggests a parallel increase in the corresponding mRNA level.
RESULTS
Two proinflammatory cytokines, IL-I a and IL-6, were tested for their ability to regulate epithelial cervical cell cytokine production and secretion and to induce proliferation of human normal and neoplastic epithelial cervical cells. In addition, their activities were compared with those of EGF. Experiments were carried out in defined serum-free medium, as FCS is complex and contains factors capable of influencing cell growth and cytokine production.
Optimal concentrations of IL-1 a and IL-6 significantly enhanced tumour and normal cell growth from 20-120% ( Figure  1 ). As expected, all neoplastic and normal cervical cells were sensitive to the stimulatory effect of EGF. The magnitude of this effect was similar to that of IL-la and IL-6 in the case of ME-180 and CaSki cell lines, whereas it was significantly higher in the remaining lines and in normal cervical cells (Student's t-test; P < 0.05 for C-33A and P < 0.005 for the other cells). The effects of IL-la, IL-6 and EGF were dose dependent (data not shown), and their stimulatory effects were observed in both HPV-infected (ME-180, C4-II and CaSki) and HPV-non-infected (HT-3, C-33A and normal) cervical cells.
To validate a possible autocrine role for IL-la, IL-6 and EGF, we analysed their secretion and expression of the corresponding mRNA by ELISA and reverse transcription-polymerase chain reaction (RT-PCR) respectively. Normal cells constitutively expressed IL-1 a, IL-6 and EGF mRNA, though at different levels (Figure 2) , the band of IL-la mRNA being more prominent than those of IL-6 and EGF.
All cell lines except C33A expressed IL-la mRNA (Table 2 ). In addition, unlike ME-l80 and C-33A, CaSki, C-411 and HT-3 expressed mRNA for IL-6. As reported in the same table, Me-180, HT3 and CaSki cells were also able to produce mRNA for EGF.
Exogenously added IL-la induced (Table 2 and Figure 3 ): (1) the expression of its own mRNA only in C33A cells that constitutively lacked IL-la mRNA; (2) the expression of IL-6 mRNA in British Journal of Cancer (1997) 75(6), [855] [856] [857] [858] [859] . Cancer Research Campaign 1997 Percentage of control Figure 4 Effects of neutralizing anti-IL-6 antibodies on the growth enhancing effect of IL-1 a, IL-6 and EGF in normal esocervical cells and in HT-3 and ME-180 cell lines. Results are expressed as percentage of control, (cell number in treated samples/cell number in untreated samples -1) x 100, and represents the mean of two different experiments, the maximal difference observed between the two being less than 20%
Me-180, and strengthened the bands relative to IL-6 mRNA in the HT-3 cell line and in normal cervical cells. Exogenously added IL-6 induced: (1) the expression of its own mRNA only in Me-180 cells that constitutively lacked IL-6 mRNA; (2) the expression of IL-la mRNA in C-33A, and strengthened the band relative to IL-la mRNA in the case of Me 180 cells. The constitutive levels of IL-la and EGF mRNAs in normal cervical cells were not modified by exogenous IL-la, IL-6 or EGF, whereas stronger bands corresponding to IL-6 mRNA were observed when these cells were treated with IL-i a.
In spite of the pattern of mRNA expression, only HT-3 and normal cervical cells constitutively secreted IL-6, and only normal cells were able to produce IL-la protein (Table 3) . A significant increase of IL-6 secretion was found in Me-180, HT-3 and normal cervical cells cultured in the presence of IL-la. The levels of EGF protein in supernatants from both stimulated and unstimulated normal and neoplastic cells were in all cases less than 10 pg ml-'.
Exogenous IL-I a and IL-6-driven cell proliferations were almost completely inhibited by the addition of neutralizing anti-IL-6 antibodies ( Figure 4 ). This antibody treatment was ineffective against EGF-stimulated cell growth.
DISCUSSION
Normal epithelial cervical cells were, as expected, highly sensitive to the stimulatory effect of EGF while neoplastic cells, though always stimulated, varied in their sensitivity to this cytokine. Both proinflammatory cytokines IL-I and IL-6 increased the growth not only of cells from neoplastic cervix, as reported (Iglesias et al, 1995; Woodworth et al, 1995) , but also of normal, non HPVimmortalized cells. Our observations on normal cervical cells slightly differ from those data showing that IL-la and IL-6 (Iglesias et al, 1995) do not affect, or only minimally increase, the growth of normal non-HPV-infected ectocervical cells. This lack of effect may be due to the absence of insulin and transferrin in the culture medium as we have found that the stimulatory effect of both these interleukins and EGF is insulin and transferrin dependent (unpublished observations). In addition, the presence of insulin and transferrin is an absolute requirement for the IL-6-and EGF-dependent proliferation of normal human epidermal keratinocytes (Elder et al, 1992) .
It is also to be noted that the modulatory effect of IL-la, IL-6 and EGF does not depend on the presence of HPV, as it is observed in HPV+ and HPV-tumour cells and in the HPV-normal counterpart. In vitro data on the effects of proinflammatory cytokines on normal and neoplastic cells suggest that they may promote growth in vivo when produced in response to inflammation or tissue damage. In this way, infection with several sexually transmitted agents becomes a risk factor for cervical neoplasia. Chronic inflammation, too, contributes to the pathogenesis of several types of cancer other than cervical forms (Correa, 1992; Kawai et al, 1993) . Many cell types contribute to cytokine production within the cervix; reactive cells, in particular macrophages, produce not only IL-lac and IL-6 but also EGF (O'Sullivan et al, 1993 ). An additional local source of IL-6 are human cervical fibroblasts, which constitutively secrete this cytokine (Iglesias et al, 1995) .
An autocrine stimulatory role of IL-l a, IL-6 and EGF is suggested by the presence of mRNA for these cytokines in both neoplastic and normal cervical cells. In spite of mRNA expression, significant protein production, by normal cells and some cancer cell lines, was only observed in the case of IL-6. Autocrine IL-6 could thus play a role in cervical cell growth, at least in some cases. IL-i a increases IL-6 mRNA expression and IL-6 secretion but does not modify these parameters for EGF. However, IL-6 plays a pivotal role in IL-la-stimulated cell growth, as anti-IL-6 antibodies abrogate the effect of IL-la.
The study of IL-6 regulatory function on growth of epithelial cervical cells is of particular interest, because increased IL-6 levels have been reported in both the serum (Breen et al, 1990 ) and cerebrospinal fluid (Gallo et al, 1989) of HIV-infected patients. In addition, in vitro infection of normal monocytes/macrophages with HIV induces gene expression and secretion of IL-6 (Nakajima et al, 1988) .
HIV-infected women form a unique subset of cervical carcinoma patients with more aggressive disease and a poorer prognosis (Maiman et al, 1990 (Maiman et al, , 1993 . This aggressiveness could be, at least, partly dependent on abnormal IL-6 production.
British Journal of Cancer (1997) 
